Literature DB >> 2021538

The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.

M C Bibby1, R M Phillips, J A Double.   

Abstract

Flavone acetic acid (FAA) is extremely active against subcutaneous transplantable tumours in mice, but disappointingly there has been no demonstrable clinical activity. Previous studies have shown that lung tumour deposits are less responsive than the same cells implanted subcutaneously. The aim of this study is to examine the tissue disposition of FAA in an attempt to explain this site-dependent activity. The data show clearly that FAA clearance curves are influenced by the presence of MAC 15A tumours growing either subcutaneously or systemically. The decreased clearance of FAA from MAC 15A tumour bearing animals does not however explain the resistance of lung deposits. Neither can this be explained by differences in metabolism in these different sites. Cytotoxic metabolites have not been detected either in vitro or in vivo and their role in the mechanism of action of FAA is questionable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021538      PMCID: PMC1972360          DOI: 10.1038/bjc.1991.127

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Transplantation of adenocarcinomas of the colon in mice.

Authors:  J A Double; C R Ball; P N Cowen
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

2.  Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors.

Authors:  D S Zaharko; C K Grieshaber; J Plowman; J C Cradock
Journal:  Cancer Treat Rep       Date:  1986-12

3.  Phase I and pharmacokinetic study of flavone acetic acid.

Authors:  D J Kerr; S B Kaye; J Cassidy; C Bradley; E M Rankin; L Adams; A Setanoians; T Young; G Forrest; M Soukop
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

4.  Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.

Authors:  M C Bibby; J A Double; S A Ali; K C Fearon; R A Brennan; M J Tisdale
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

5.  Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Authors:  T H Corbett; M C Bissery; A Wozniak; J Plowman; L Polin; E Tapazoglou; J Dieckman; F Valeriote
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

6.  Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.

Authors:  J Plowman; V L Narayanan; D Dykes; E Szarvasi; P Briet; O C Yoder; K D Paull
Journal:  Cancer Treat Rep       Date:  1986-05

7.  Dose-dependent pharmacokinetics of flavone acetic acid in mice.

Authors:  G Damia; M L Zanette; C Rossi; R Mandelli; A Ferrari; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts.

Authors:  R Giavazzi; A Garofalo; G Damia; S Garattini; M D'Incalci
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

9.  Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

Authors:  D J Kerr; T Maughan; E Newlands; G Rustin; N M Bleehen; C Lewis; S B Kaye
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

10.  Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.

Authors:  J A Double; M C Bibby; P M Loadman
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.